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Femoral vein transposition for arteriovenous
hemodialysis access: Improved patient selection
and intraoperative measures reduce postoperative
ischemia
Wayne S. Gradman, MD, Judith Laub, MD, and William Cohen, MD, Los Angeles, Calif
Purpose: Construction of prosthetic arteriovenous access for hemodialysis in the thigh results in a high incidence of graft
failure and infection. Autogenous femoral artery–common femoral thigh transposition (transposed femoral vein [tFV])
arteriovenous accesses have superior patency, but our previous report documented a high incidence of ischemic events
requiring secondary surgical intervention. Recent results of improved patient selection and intraoperative maneuvers to
reduce ischemia are unknown.
Methods: During a 6-year period eight children (mean age, 13.3 years) and 46 adults (mean age, 52.3 years; 27 female, 19
male) underwent construction of 55 tFV thigh accesses for hemodialysis access. Adult patients were divided into groups
I and II on the basis of the introduction of specific strategies to reduce the incidence of ischemic complications. In the
cohort of children, steal prophylaxis included one banded femoral vein, three tapered femoral veins, two distal femoral
artery pressure measurements taken before and after access construction (mean ratio, 0.70), and two closed anterior and
superficial posterior compartment fasciotomies. Of the first 25 accesses in adults (group I, mean age, 55.9 years), 10 had
access banding (six at the initial procedure and four in the immediate postoperative period to treat ischemia). Of the
second 22 accesses (group II, mean age, 48.2 years), steal prophylaxis included 14 tapered femoral veins, 6 distal femoral
artery pressure measurements (mean ratio, 0.76; range, 0.62 to 0.86), and 1 fasciotomy. Patients with significant distal
occlusive disease were not offered a tFV access in the time frame of group II.
Results:Eight accesses in children had 100% primary functional patency at 2 years, with no reoperations for ischemia. Nine
group I adult patients underwent remedial procedures to correct distal ischemia. No adult patient in group II required
a remedial procedure to correct ischemia. Groups I and II 2-year secondary functional access patency was 87% and 94%,
respectively. There were no access infections in either group. Femoral vein tapering significantly reduced the need for
remedial correction of ischemia (P  .03).
Conclusions: Improved patient selection and selective intraoperative femoral vein tapering eliminated remedial procedures
to correct ischemia in patients undergoing tFV access. Patency rates were excellent despite the liberal use of vein tapering.
Transposed FV access should be considered for good risk individuals undergoing their first lower extremity access.
(J Vasc Surg 2005;41:279-84.)Our recent report of 25 autogenous superficial femoral–
common femoral thigh transposition (transposed femoral vein
[tFV]) arteriovenous accesses for hemodialysis indicated a
2-year secondary patency rate of 87%, minimal morbidity
from edema, and no access infections.1 Nine of our first 26
patients, however, developed an ischemic complication re-
quiring remedial surgical intervention. In an attempt to re-
duce the incidence of postoperative ischemic complications in
subsequent patients,we excludedpatientswith distal occlusive
disease and initiated prophylactic intraoperative measures to
avoid ischemia, yet maintain good patency rates. This report
compares outcomes of both patient cohorts to determine the
efficacy of these measures.
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BetweenMarch 1998 and December 2003, 54 patients
underwent elective construction of 55 tFV accesses for
hemodialysis. One patient had bilateral procedures.
Follow-up was completed through July 2004. All candi-
dates for the procedure were deemed to have exhausted or
have a specific contraindication to an upper extremity ac-
cess. Preoperative studies in selected patients included
ankle-brachial indices and femoral vein duplex ultrasound
scanning. The basic technique of tFV access construction is
described in our initial publication.1Briefly, the femoral
vein, in continuity with a variable length of supragenicular
popliteal vein, is mobilized from the popliteal fossa to the
junction of the femoral vein with the profunda femoris vein.
The vein is transposed superficially, analogous to an autog-
enous brachial-basilic upper arm transposition (basilic vein
transposition), and implanted on the distal femoral artery
between the divided adductor tendon and the inferior
border of the sartorius muscle.
Patients were divided into two groups on the basis of
the introduction of specific strategies to reduce the inci-
dence of ischemic complications. In group I (n  26,
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postoperative ischemia in selected individuals were access
banding and, in individuals with arterial occlusive disease,
either origination of the access from the distal end of a
prosthetic femoropopliteal bypass graft or construction of a
composite prosthetic-femoral vein femoral inguinal looped
access. Group I includes the 25 originally published pa-
tients along with the twenty-sixth patient in the series. In
group II (n 29, August 2000 to July 2004) we excluded
individuals with significant arterial occlusive disease (a re-
quirement for a sequential or composite access, absent
pedal pulses, or an ankle-brachial index of 0.85) and
individuals who were both old and frail. Intraoperative
measures used to avoid postoperative ischemia in selected
group II individuals included tapering of the femoral vein
at the takeoff from the distal femoral artery (Fig 1), closed
anterior and superficial posterior compartment fascioto-
mies when pulses were very weak or absent immediately
after access construction, and measurement of proximal
popliteal artery pressure after access construction. The ratio
Fig 1. In selected cases, the femoral vein is tapered to a 4.5- to
5.0-mm diameter (A) before implantation on the distal femoral
artery (B).of this pressure to that obtained with the access temporarilyoccluded provides an index of access-induced pressure re-
duction. A value of 0.6 was accepted as not likely to induce
clinical ischemia. For each tFV candidate, the decision
whether to use one or more intraoperative measures to
avoid postoperative ischemia was left to the surgeon’s dis-
cretion.
We generally followed the recommended Vascular So-
ciety reporting standards for arteriovenous hemodialysis
access surgery.2 An access requiring polytetrafluoroethyl-
ene (PTFE) to maintain patency or relieve ischemia was
considered secondarily patent if both hemodialysis access
needles could be placed in the femoral vein. Access aban-
donment was recorded as failure of secondary patency. The
main outcomes studied were primary and secondary func-
tional access patency, as well as freedom from remedial
surgery to treat a postoperative ischemic complication
(pedal ischemia, a compartment syndrome, or ischemic
monomelic neuropathy). Patients with ipsilateral below
knee amputations were excluded from analysis of reopera-
tion for ischemia.
The outcomes in children (age,21 years; n 8) were
analyzed separately to provide meaningful results for the
more commonly encountered adult hemodialysis popula-
tion. Thus, group I was left with 25 adult accesses and
group II with 22 adult accesses.
Patient characteristics and comorbidities, as well as
other comparisons between groups, were analyzed with the
Fisher exact test or Student t distribution. Kaplan-Meier
curves were constructed for primary and secondary func-
tional patency, as well as for freedom from reoperation for
ischemia. The log-rank statistic was used to compare group
I and II survival curves for primary and secondary patency,
and freedom from reoperation for ischemia, and to com-
pare tapered and nontapered accesses for effectiveness in
avoiding reoperation for ischemia. A Cox proportional
hazards regression was used to identify factors possibly
contributing to access failure and reoperation for ischemia.
The Cedars-Sinai Medical Center Institutional Review
Board approved this study (4460-01).
RESULTS
Tables I and II outline patient characteristics and co-
morbidities for all patients.
Children. Of eight children, one had femoral vein
banding, three had femoral vein tapering, two had closed
anterior and superficial posterior compartment fascioto-
mies, and two had access induced pressure ratios of 0.68
and 0.75. The 2-year primary and secondary functional
access patency was 100%, with no reoperations for isch-
emia. One child developed a lymphocutaneous fistula that
was closed surgically 3 weeks after access construction.
Adults. Although group I adult patients had propor-
tionally greater women, diabetics, older patients, and com-
posite accesses than those in group II, none of these differ-
ences was significant.
No patient in the time period of the first 25 adult
patients (group I) was excluded solely because of distal
occlusive disease. Twenty of these patients had straight
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artery. Five had either a composite femoral vein–prosthetic
looped (4) or sequential (1) access originating on the
common femoral artery. Ten accesses were banded either
intraoperatively (6) or in the immediate postoperative pe-
riod (4) to avoid or treat ischemia. Nine patients manifested
evidence of ischemia in the postoperative period (distal
ischemia, 6; compartment syndrome, 2; ischemic
monomelic neuropathy, 1). Procedures to alleviate isch-
emia included various combinations of distal bypass with-
out interval ligation, conversion to a looped access, iliac
artery angioplasty, fasciotomy, access banding, and access
ligation. One individual eventually had an above knee
amputation. Three banded accesses lost primary patency in
the follow-up period.
In the time period of the subsequent 22 adults (group
II), patients lacking pedal pulses were not considered for a
tFV access. None of the group II patients had access
banding. There were 14 tapered femoral veins, 1 closed
anterior and superficial posterior compartment fasciotomy,
and 6 measurements of distal femoral artery pressure, all
but one in accesses that were tapered (mean, 0.75; range,
0.62 to 0.86). No patient required a remedial procedure for
ischemia. No tapered access lost primary patency in the
follow-up period. There were no major wound complica-
tions or graft infections in the adult group II.
Kaplan-Meier functional patency curves for groups I
Table I. Clinical characteristics of patients who had
femoral vein transposition for hemodialysis access created
in two successive time intervals
Group I
(n  26)
Group II
(n  29)
P
value
Children (n  8) 1 7
Age (mean, y) 19.0 12.4
Adults (n  47) 25 22
Age (mean, y) 55.9  3.0 48.2  2.9 .08
Female/male 18/7 10/12 .08
Diabetes
mellitus
15 (60%) 7 (32%) .08
Ipsilateral
amputation
3 (12%) 1 (4%) .61
Table II. Comorbidities of two groups of adults (n 
47) who had creation of a femoral vein transposition
access for hemodialysis
Group I
(n  25)
Group II
(n  22) P value
Option of placing access in
either leg (%)
44 (11) 91 (20) .0008
Composite tFV-PTFE
access created at initial
surgery (%)
20 (5) 0 (0) .05
tFV banded at initial
surgery (%)
36 (9) 0 (0) .001
tFV tapered at initial
surgery (%)
0 (0) 64 (14) .0001and II are shown in Figs 2 and 3. Although there isincreased primary and secondary access patency in group II,
the differences are not significant. There is, however, a
significant difference between groups (Fig 4) when reop-
eration for ischemia is considered (P  .001). The Cox
regression identified no characteristic or comorbidity af-
fecting functional access patency or reoperation for isch-
emia. Compared to nontapered accesses, tapered accesses
significantly reduced the incidence of reoperations for isch-
emia (P  .03). The difference in access thrombosis be-
tween banded and tapered accesses is also significant (P 
.05).
DISCUSSION
National Kidney Foundation-Dialysis Outcomes Qual-
ity Initiative clinical practice guidelines first published in
Fig 2. Kaplan-Meier primary and secondary functional patency
curves for adult patients in group I.
Fig 3. Kaplan-Meier primary and secondary functional patency
curves for adult patients in group II.19973 discouraged subclavian vein catheters and advocated
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fistulas, each of which should result in a reduced need for
lower extremity access construction. Nonetheless, in our
large urban population (greater Los Angeles), where surgi-
cal skills vary widely and prosthetic access construction is
still the norm, a small but stubborn percentage of patients
eventually require lower extremity access. Most of our
patients had their initial accesses placed in other communi-
ties.
When upper extremity access is exhausted, most sur-
geons construct a prosthetic inguinal looped access.4-9 A
recent landmark study of these accesses by using the stan-
dards recommended by the Vascular Societies reported
2-year primary and secondary patency rates of 19% and
54%, respectively, an overall infection rate of 41%, and an
11% incidence of ipsilateral limb ischemia.9 Reports of
access construction with cryopreserved veins and bovine
mesenteric bioprosthetic grafts show some outcomes im-
provement over PTFE,10,11 but not attaining the high
levels of patency and freedom from complications seen with
autogenous vein in the upper extremity.12 Saphenous vein
accesses are occasionally successful,13 but in our experi-
ence, the saphenous vein is an unreliable conduit because of
its relatively small size and unfavorable position for trans-
position.
Our original report of 25 tFV accesses showed good
functional 2-year primary and secondary patency rates but
an alarming incidence of ischemic complications requiring
reoperation.1 Rather than abandon the procedure entirely,
we identified four factors possibly responsible for the in-
creased incidence of ischemia compared to an inguinal
looped or arm access, and we initiated appropriatemeasures
to mitigate them, beginning with the twenty-seventh pa-
tient in our series.
One factor contributing to ischemia might relate to the
initiation of the access on the distal femoral artery rather
than in the groin.14 Unfortunately, there is rarely sufficient
Fig 4. Kaplan-Meier curves for freedom from reoperation for
ischemia for adult patients in groups I and II.femoral/popliteal vein to loop back to the common femo-ral artery, and we believed that lengthening the access with
PTFE would defeat the advantages of an all-autogenous
access. Neither of these procedures was considered for
group II patients.
The second factor contributing to the relative increase
in ischemic complications, especially when comparing a
tFV to upper extremity accesses, is the increased prevalence
of arterial occlusive disease and calcification (stiffness) in
lower extremity vessels. Although this factor does not ex-
plain why ischemic steal is infrequently seen when con-
structing a prosthetic inguinal looped access, it did suggest
that one prudentmeasure to reduce ischemic complications
would be to exclude individuals with significant arterial
occlusive disease.
Vascular surgeons commonly encounter compartment
syndromes in the setting of ischemia-reperfusion. A recent
study of fasciotomy after femoral vein harvest for complex
vascular reconstruction suggested that the compartment
syndromes result from combined ischemia-reperfusion and
venous hypertension.15 Two of our group I patients expe-
rienced a postoperative compartment syndrome after tFV
construction, suggesting that a combination of “steal”
ischemia and venous hypertension alone, without reperfu-
sion, is sufficient to develop a compartment syndrome.16
We further reasoned that increased postoperative ischemia
might enhance the likelihood of a compartment syndrome,
and therefore we performed prophylactic closed anterior
and superficial posterior compartment fasciotomies in three
group II patients with marginal or absent pulses immedi-
ately after tFV construction. We did not, however, measure
compartment pressures in patients having either prophylac-
tic or therapeutic fasciotomies.
The fourth factor relates to conduit size mismatch
between artery and vein.17 In a nontransposed arterio-
venous fistula, an increase in fistula anastomotic diameter
greater than the diameter of the proximal artery does not
appear to increase fistula flow.18 On the other hand, access
flow does increase in bridge grafts when the diameter of the
bridge graft exceeds the diameter of the proximal artery.19
In this regard, the tFV resembles a bridge graft. Because the
distal femoral vein is frequently 8 mm or larger, we ad-
dressed this issue by tapering the femoral vein to a diameter
of 4.5 to 5 mm before implanting it on the femoral artery.20
Preimplantation access tapering reduces flow while main-
taining access patency more reliably than postconstruction
access banding.20,21 Vein tapering was not used when the
femoral vein was relatively small compared to the femoral
artery. Our initial success in preserving distal pulses and
avoiding postoperative ischemia persuaded us to use this
prophylactic measure in 17 group II patients.
In addition to introducing specific prophylactic mea-
sure based on these four factors, we also monitored popli-
teal artery pressures before and after temporary occlusion of
the newly constructed access in selected patients as de-
scribed by Knox et al.22 Because previous clinical studies
suggest development of the steal syndrome is rare with a
pre/post compression ratio of 0.50,19,21 we arbitrarily
selected a cutoff ratio of 0.60 as a level not requiring
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tive ischemia.19,22 All eight patients tested in this fashion
had a ratio of greater than 0.60.
We elected to analyze the results of children separately
from those of adults, because most vascular surgeons do
not provide access for this cohort, and children are not
vulnerable to the potential confounding contribution of
arteriosclerotic occlusive disease to ischemia. The primary
and secondary patencies and complete freedom from isch-
emic complications and infection in this cohort suggest that
tFV is superior to a prosthetic conduit in children who
cannot have upper extremity access.23
With a functional secondary 2-year patency rate of 94%
and complete freedom from ischemic complications, the
adults in group II fared better than those in group I, as well
as those in other published studies of prosthetic inguinal
looped grafts.
The complete absence of access infection in the overall
series of 55 accesses contrasts strikingly with other series4-9
(11% to 41%) reporting prosthetic inguinal looped accesses.
When fistula revision with PTFE was used to maintain
access patency or correct ischemia, we deliberately tunneled
the PTFE deeply, obliging technicians to cannulate only
the more superficially placed femoral vein. We believe that
access infection results from frequent cannulation of PTFE.
The shortcomings and limitations of our study merit
discussion. Both our original series and the present study
are retrospective analyses of our experience with tFV. The
procedure was introduced to treat a specific population of
patients, namely those who require a new lower extremity
access. We believe that population has changed somewhat
during the 6 years we have undertaken this study. The early
patients, often the product of numerous failed lower ex-
tremity accesses, were sicker and older than our later pa-
tients, in whom tFV was more frequently done as the
individual’s first lower extremity access.
Furthermore, the sex and diabetic status of our group
II adult patients are notably but not significantly different
from our group I patients. We believe these differences,
each seemingly favoring the group II patients, are entirely
coincidental and not due to a subtle bias in patient selec-
tion.
Our reassessment of the operation after the twenty-
sixth patient resulted in introduction of several promising
measures to reduce ischemia. The use of any givenmeasure,
however, was always at the discretion of the surgeon,
because it was not known which, if any, of these measures
would prove effective. In such an exploratory study without
controls and specific guidelines, it is difficult to establish the
efficacy of any single measure, especially because multiple
measures were used in some individuals. In retrospective
analysis, only vein tapering emerges as a strong candidate
for additional study and possible verification of efficacy. It
should be noted that the decision whether to taper a
femoral vein in group II was not always a random event,
because some veins were considered relatively small and
some arteries were relatively large. In each instance in whichaccess tapering was not used, however, the surgeon guessed
correctly that a steal would be unlikely.
The potential benefit of fasciotomy is unknown—in
part because only three patients had the procedure, and in
part because the pathophysiology of compartment syn-
drome development in our two group I patients remains
poorly understood. Likewise, the role of intraoperative
pressure measurement remains unclear, because the
premise that a ratio 0.60 is unacceptable remains un-
tested. For anyone choosing to measure these pressures,
however, it should prove comforting to find a ratio0.60.
Direct comparison between the outcomes of our group
II accesses and those of other studies is also limited. We
rejected a small but not prospectively tallied number of
candidate patients because of arterial occlusive disease and
frail old age. These patients underwent a prosthetic ingui-
nal looped access instead.
The relatively small group sizes under study limit the
power of our conclusions, especially after the cohort of
children is removed from our comparison of groups I and
II. Nevertheless, we believe that the mere knowledge of
potential ischemia during the time frame of group II led us,
and could lead others, to increased intraoperative vigilance
and selective use of effective measures, especially vein taper-
ing, to prevent postoperative ischemia.
In conclusion, a tFV access can be constructed with
excellent patency and minimal ischemia and infection. It
should be considered the first choice for lower extremity
access in good risk individuals.
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Dr Ronald Webb (Oakland, Calif). This study covers 6 years
of difficult work. Dr Gradman used what he learned from group 1
to improve his results in group 2. The audience should recognize
that there are eight children in this series. Adult patients should
have palpable pedal pulses or ankle-brachial indices greater than
0.85 to get good results. The large femoral vein was tapered to
avoid steal in 14 of the 22 patients. Of note, no graft in either
group 1 or group 2 was removed for infection. Dr Cull found 41%
of his femoral PTFE grafts were infected in the longest study in the
literature. I have three questions for Dr Gradman. First, would you
transpose the femoral vein to the upper extremity if a basilic vein
target were available? Second, would you share your technique of
revision and thrombectomy of the femoral vein graft with the
audience? Third, do you have any idea of how many patients you
evaluated but excluded before performing the femoral vein trans-
position in the second group?
Dr Wayne S. Gradman. Thank you, Dr Webb. We don’t
transpose the femoral vein to the upper extremity as Dr Huber
does. Basically, we don’t want to harm two extremities at once. We
would rather exhaust the upper extremities with PTFE before
moving to the lower extremity. On the other hand, we don’t do
necklace grafts, ax-fem grafts, or grafts to the jugular vein.
Thrombectomy and access revision is an interesting issue.
Clotted basilic and cephalic vein accesses are very difficult to open
and keep open. It’s a lot easier in the lower extremity with the
femoral vein. The femoral vein is a big conduit and you are
accessing it using only a quarter of its circumference, so that when
you actually need to clean one out, you usually find that the body
of the access is quite disease-free. The problem is usually at either
the arterial anastomosis or at the junction of the femoral vein and
the common femoral vein, and about half the time those problems
can be treated either with balloon angioplasty or interposed PTFE.
At the arterial end, where reoperation can be a bit challenging, Ithe common femoral artery. That’s actually a fairly simple opera-
tion. At the venous end, I have patched the femoral vein stenosis
with a double width of saphenous vein (rather than spiral vein) to
maintain the large lumen size.
Finally, the issue of how many patients we evaluated but
excluded is important, since it makes any comparison of our series
to those of Drs Cull and Glickman a bit problematic. We don’t
believe this operation is for everybody. However, in the second
group I personally performed the operation in over 20 patients and
I excluded only two patients. My two colleagues and coauthors,
however, are not database keepers, so I can’t tell you our exact
numbers. Surprisingly, most candidates we evaluate have pedal
pulses.
Dr Gregory L. Moneta (Portland, Ore). Dr Gradman, do
you look at the femoral vein ahead of time with duplex scanning to
ensure that it hasn’t had a previous thrombus before you do this
procedure?
Dr Gradman. Yes, we always try to scan the femoral vein for
size, DVT, duplications, et cetera before we use this procedure.
But we’ve been burned a couple of times with unexpected iliac vein
disease.
Dr Ronald Dalman (Stanford, Calif). Are there any tricks to
tunneling the femoral vein?
Dr Gradman. Yes, there are. I make two counterincisions to
facilitate the tunneling and to try to avoid acute angles at either
end. Between these two counterincisions is where the vein will be
accessed. You don’t need much length between those incisions,
about 15 centimeters is OK. It is interesting that all the wound
complications we experienced involved necrosis on the medial flap
of the incision, never on the lateral one, so I feel comfortable
keeping the vein within 2 or 3 centimeters of the main incision.
That way I conserve length, particularly in obese patients, where
every millimeter counts.
